1nKemia IUCT Group, S.A. (BME: IKM)
Health Care · Biotechnology · ES
€—
— today · — 1Y
1nKemia IUCT Group, S.A. (BME: IKM) operates in the Biotechnology industry within the Health Care sector. The company is valued at $8.80M.
Tweenvest scores 1nKemia IUCT Group, S.A. across four factors: quality 29/100, value 43/100, growth 0/100. Its strongest factor is value.
IKM price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $8.80M
- Revenue (TTM)
- $5.18K
- P/E
- —
- EPS
- -0.00
- Dividend yield
- —
- Beta (5Y)
- 0.00
- 52-week high
- €—
- 52-week low
- €—
- Avg volume (3M)
- —
- Shares outstanding
- 26.91M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Poxel S.A.ENXTPA: POXEL | $8.95M | €0.15 | +10.45% |
| AdAlta LimitedASX: 1AD | $8.94M | AU$0.00 | +14.29% |
| Biovica International AB (publ)OM: BIOVIC B | $8.90M | Skr0.30 | -0.33% |
| Vistagen Therapeutics, Inc.NasdaqCM: VTGN | $8.88M | $0.20 | -15.29% |
| Nanologica AB (publ)OM: NICA | $8.66M | Skr0.26 | -5.78% |
| Brainstorm Cell Therapeutics Inc.OTCPK: BCLI | $8.60M | $0.78 | -17.94% |
| Chemomab Therapeutics Ltd.NasdaqCM: CMMB | $8.55M | $1.18 | +0.85% |
| Lantern Pharma Inc.NasdaqCM: LTRN | $8.54M | $0.67 | -17.76% |
Figures last refreshed Oct 18, 2026.